Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (Q3)Jun 30, 2025 | (Q2)Mar 31, 2025 | (Q1)Dec 31, 2024 | (FY)Sep 30, 2024 | (Q4)Sep 30, 2024 | (Q3)Jun 30, 2024 | (Q2)Mar 31, 2024 | (Q1)Dec 31, 2023 | (FY)Sep 30, 2023 | (Q4)Sep 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 327.59%257.88K | -386.15%-543.86K | -161.01%-125.57K | -5.85%83.05K | 732.75%315.19K | -148.65%-113.31K | 74.70%-111.87K | -113.15%-48.11K | 120.82%88.21K | -4.53%-49.81K |
| Net income from continuing operations | 33.95%-86.93K | 24.81%-261.2K | 88.19%-26.22K | -41.79%-952.56K | -6.16%-260.72K | 33.26%-131.61K | -5,971.87%-347.38K | 5.54%-221.94K | -7.45%-671.81K | -60.99%-245.59K |
| Operating gains losses | -445.67%-7.46K | 124.35%2.45K | 420.81%17.73K | -70.57%17.73K | --0 | 123.99%2.16K | -24.82%-10.04K | 65.28%-5.53K | -10.05%60.24K | 68.12%93.2K |
| Depreciation and amortization | -3.67%36.53K | -4.27%36.25K | -5.33%35.75K | -4.11%158.23K | 1,136.16%44.68K | -33.18%37.92K | -30.53%37.87K | -24.68%37.76K | -17.78%165.02K | -92.17%3.61K |
| Remuneration paid in stock | --0 | --0 | --0 | -64.72%27.15K | 100.00%-1 | -96.45%4.04K | --11.5K | --11.62K | --76.96K | ---36.9K |
| Other non cashItems | -7.70%16.31K | -7.34%16.67K | -4.22%17.02K | 195.32%71.41K | 179.88%26.84K | -6.83%17.67K | -6.61%17.99K | -9.11%17.77K | -70.14%24.18K | -284.66%-33.6K |
| Change In working capital | 787.97%299.43K | -289.70%-338.03K | -251.38%-169.86K | 75.52%761.09K | 203.23%513.86K | -117.44%-43.52K | 134.68%178.19K | -79.49%112.2K | 394.90%433.63K | 1,238.78%169.46K |
| -Change in receivables | 137.36%130.22K | -501.70%-305.89K | -632.97%-145.89K | 14.94%94.19K | 394.13%339.21K | -450.38%-348.55K | 134.25%76.15K | -90.84%27.37K | 9,401.25%81.94K | 168.30%68.65K |
| -Change in inventory | 58.26%296.57K | -47.29%139.76K | -154.99%-335.57K | -14.73%566.23K | -16.26%246.96K | 20,163.60%187.39K | 43.26%265.14K | -171.12%-131.6K | 565.07%664.07K | 902.77%294.91K |
| -Change in prepaid assets | 131.14%37.07K | 339.85%192.32K | -590.90%-221.07K | 269.35%116.81K | 130.60%12.01K | -88.64%16.04K | 136.05%43.72K | 190.68%45.03K | -135.72%-68.97K | -105.68%-39.26K |
| -Change in payables and accrued expense | -261.85%-164.43K | -76.10%-364.22K | 210.78%532.67K | 93.37%-16.14K | 45.54%-84.33K | -41.11%101.59K | 41.80%-206.82K | 51.95%171.4K | -23.88%-243.41K | -209.47%-154.84K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 327.52%257.88K | -386.14%-543.86K | -161.01%-125.57K | -5.85%83.05K | 751.76%324.66K | -148.67%-113.34K | 74.70%-111.87K | -113.15%-48.11K | 120.82%88.21K | -4.53%-49.81K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -1.80%32.36K | 14.83%35.19K | -0.11%29.53K | 720.54%128.16K | -64.16%33.5K | 2,192.51%32.96K | 40.12%30.64K | 122.00%29.56K | -44.58%-20.65K | 701.89%93.46K |
| Net PPE purchase and sale | ---3.69K | --0 | -200.87%-4.51K | 92.87%-1.5K | --0 | --0 | -105.41%-1.5K | 98.88%-1.5K | -47.27%-21.04K | -214.21%-48.79K |
| Net other investing changes | 9.41%36.06K | 9.47%35.19K | 9.59%34.04K | 33,665.63%129.66K | -76.45%33.5K | 2,192.51%32.96K | 646.67%32.14K | --31.06K | --384 | --142.24K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -1.80%32.36K | 14.83%35.19K | -0.11%29.53K | 720.54%128.16K | -64.16%33.5K | 2,192.51%32.96K | 40.12%30.64K | 122.00%29.56K | -44.58%-20.65K | 701.89%93.46K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 50.83%-57.73K | 23.93%-49.62K | -24.61%-61.9K | 8.34%-206.69K | 65.90%-53.7K | -411.34%-117.42K | -55.57%-65.23K | -122.11%-49.67K | -37.21%-225.48K | -294.26%-157.49K |
| Net issuance payments of debt | 50.83%-57.73K | 23.93%-49.62K | -24.61%-61.9K | 8.34%-206.69K | 65.90%-53.7K | -411.34%-117.42K | -55.57%-65.23K | -122.11%-49.67K | -37.21%-225.48K | -294.26%-157.49K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 50.83%-57.73K | 23.93%-49.62K | -24.61%-61.9K | 8.34%-206.69K | 65.90%-53.7K | -411.34%-117.42K | -55.57%-65.23K | -122.11%-49.67K | -37.21%-225.48K | -294.26%-157.49K |
| Net cash flow | ||||||||||
| Beginning cash position | -7.08%472.75K | -27.75%514.74K | -12.90%655.53K | -15.41%752.59K | -57.94%343.36K | -15.32%508.78K | -33.82%712.44K | -15.41%752.59K | -40.48%889.73K | -8.18%816.43K |
| Current changes in cash | 217.55%232.51K | -281.19%-558.3K | -131.52%-157.94K | 102.86%4.52K | 367.42%304.46K | -194.94%-197.8K | 68.32%-146.46K | -132.61%-68.22K | 73.78%-157.93K | -10.40%-113.85K |
| Effect of exchange rate changes | -1,399.39%-420.78K | 1,044.74%540.37K | -38.93%17.14K | -588.61%-101.58K | -84.57%7.72K | 346.85%32.38K | -325.19%-57.2K | 225.81%28.07K | 851.90%20.79K | -51.77%50.01K |
| End cash Position | -17.15%284.48K | -2.35%496.81K | -27.75%514.74K | -12.90%655.53K | -12.90%655.53K | -57.94%343.36K | -15.32%508.78K | -33.82%712.44K | -15.41%752.59K | -15.41%752.59K |
| Free cash from | 324.26%254.19K | -379.71%-543.86K | -162.22%-130.08K | 21.41%81.55K | 558.24%324.66K | -148.67%-113.34K | 74.36%-113.37K | -121.43%-49.61K | 115.34%67.17K | -14.38%-70.85K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.